9Nakamura T,Fukui M,Ebihara I,et al.Abnormal gene expression of matrix metalloproteinases and their inhibitor in glomerular from diabetes rats[J].Renal Physiol Biochem,1994,17(6):316-325.
10Suzuki D,Miyazaki M,Jinder K,et al.In situ hybridization studies of matrix metalloproteinases 3,tissues inhibitor of metalloproteinases -1 and Ⅳ collagen in diabetic nephropathy[J].Kidney Int,1997,52(1):111-119.
二级参考文献39
1Zhang BP, Ye S, Herrmann SM, et al. Functional polymorphism in the regulatory region of gelatinase B gen in relation to severity of coronary atherosclerosis. Circulation, 1999,99:1788-1794.
2Bennett MR. Apoptosis of vascular smooth muscle cells in vascular remodelling and atheroslerotic plaque rupture. Cardiovasc-Res, 1999,41 :361-368.
3Rekhter MD, Hicks GW, Brammer DW, et al. Hypercholesterolemia causes mechanical weakening of rabbit atheroma: local collagen loss as a prerequisite of plaque rupture. Cire-Res ,2000,86 : 101-108.
4Xu XP, Meisel SR, Ong JM, et al. Oxidized low-density lipoprotein regulates matrix metalliproteianse-9 and its tissue inhibitor in human monocyte-derived macrophage. Circulation, 1999 24:993-998.
5Mach F, Schonbeck U,Bonnefoy JY, et al. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40. Circulation, 1997,96:396-399.
6Still K,Robson CN,Autzen P,et al.Localization and quantification of mRNA for matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of matrix metalloproteinase 2(TIMP-2) in human benign and malignant protatic tissue.Prostate,2000,42 (2):18-25.
7Gohji K,Fujimoto N.Serum matrix metalloproteinase-2 and density in men with prostate cancer as a new predictor of disease extension.Int J Cancer,1998,79 (11):96-101.
8Arii S,Mise M,Harada T,et al.Overexpression of matrix metalloproteinase-9 gene in hepatocellular carcinoma with invasive potential.Hapatolog,1996,24(2):316-319.
9Okazaki L,Wada N,Nakano M,et al.Difference in gene expression for matrix metalloproteinase-1 between early and hepatocellular carcinomas.Hepatol,1997,25(3):580-584.
10Hayasaka A,Suzuki N,Fujimoto N,et al.Elevated plasma levels of matrix metalloproteinase-9(92kd type collagenase / gelatinase B ) in hepatocellular carcinoma.Hepatol,1996,24 (5):1058-1062.
3Mclennan SV,Kelly DT,Cox AJ,et al.Decreased matix degradation in diabetic nephropathy:efects of ACE inhibition on the expression and activities of matrix metallopro-teinases[J].Diabetologia,2002,45(2):268.
4Benigni A,Tomasoni S,Gagliardini E,et a.l Blocking angiotensin Ⅱ synthesis/activity preserves glomerular nephrin in rats with severe nephrosis[J].J Am Soc Nephro,2001,12(3):941-948.
5Fischer KG,Saueressig U,Jacobshagen C,et al Extracellular nucleotides regulate cellular functions of podocytes in culture[J].Am J Physiol Renal Physio,2001,281(4):F1075-F1081.
6Notari L,Miller A,Martinez A,et al.Pigment epithelium derived factor is a substrate form matrix metallopmteinase type2 and type 9:implications for down regulation in hypoxia[J].Invest Ophthalmol Visl Sci,2005,46:2736-2747.
7Lote Louise,Abrahamowicz Michal,Rodrigues,et al.Mortality rates in elderly patients who take different angiotensin-converting enzyme inhibitors after acute myocardial infarction:a class effect[J]? Ann Intern Med,2004;141(2):102-12.
8Sauer WH,Baer JT,Berlin JA,et al.Class effect of angiotensin-converting enzyme inhibitors on prevention of myocardial infarction[J].Am J Cardio,2004;94(9):1171-3.
